课题基金 / 基金详情

A population-based assessment of the cardiovascular effects of 5-alpha reductase inhibitors

A population-based assessment of the cardiovascular effects of 5-alpha reductase inhibitors
基于人群的 5-α 还原酶抑制剂心血管效应评估
批准号：
303555
负责人：
Filion Kristian B
金额：
$11.31万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-03-01 至 2016-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=303555&lang=en
关键词：
5-Alpha Reductase Inhibitors Benign Prostatic Hyperplasia Cardiovascular Disease Drug Safety Heart Failure Myocardial Infarction Pharmacoepidemiology Side Effects Stroke

项目摘要

项目成果

Filion Kristian B的其他基金

相似基金

相关文献

中文摘要
翻译
这类被称为5- α还原酶抑制剂的药物通常用于治疗前列腺肥大的男性，这种疾病被称为良性前列腺增生或BPH。先前的研究表明，这些药物可以改善前列腺增生的症状，降低前列腺增生
英文摘要
The class of drugs called 5-alpha reductase inhibitors are commonly used to treat men with enlarged prostates, a condition called benign prostatic hyperplasia or BPH. Previous studies have shown that these drugs improve the symptoms of BPH and decrease th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparative Effectiveness of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin for the Prevention of Micro- and Macrovascular Complications Among Patients with Type 1 Diabetes
The Safety of Antipsychotic Drugs Among Children and Youth With Attention Deficit and Hyperactivity Disorder
Comparative Effectiveness and Safety of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin among Patients with Type 2 Diabetes
A population-based assessment of pharmacological treatments for gestational diabetes
海外基金